This report presents data on national estimates of substance-related ED visits from 53 participating DAWN hospitals in 2023. The data includes (1) all drug-related ED visits, (2) the top substances involved in drug-related ED visits, (3) opioid-related ED visits by type, and (4) polysubstance-related ED visits.